Analytical Data
-
Gene name
MAPK1IP1L
- Application
-
Alternative Names
(Mitogen-activated protein kinase 1-interacting protein 1-like)
-
Species
Human
-
Source
HEK293
-
Tag
C- hFc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NDC0
-
Expression Region
2-245aa
-
Molecular Weight
53.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MAPK1IP1L (Mitogen-Activated Protein Kinase 1 Interacting Protein 1-Like) is a relatively less-studied protein that has been implicated in various cellular processes, including stress responses and signal transduction pathways. It is known to interact with MAPK1 (also known as ERK2), a crucial component of the MAPK signaling cascade, which plays a significant role in regulating cell proliferation, differentiation, and apoptosis. The study of MAPK1IP1L has garnered attention due to its potential involvement in cancer and other diseases, as dysregulation of the MAPK pathway is often associated with tumorigenesis. Recent advancements in recombinant protein technology have facilitated the production of MAPK1IP1L in heterologous systems, allowing for detailed biochemical characterization of the protein and investigation of its functional role in the cell. Understanding the structure-function relationship of MAPK1IP1L can provide valuable insights into its contributions to signaling networks and its potential as a therapeutic target. Moreover, exploring the mechanisms by which MAPK1IP1L modulates MAPK activity could reveal novel regulatory pathways and broaden our comprehension of cellular dynamics in health and disease. Overall, MAPK1IP1L represents a promising research avenue within the broader context of MAPK signaling and its implications in various biological processes.
